Early to mid-stage gastric cancer is potentially curable with aggressive treatment, depending on the stage and type of pathology cytology.
Patients with early-stage gastric cancer recover well with aggressive treatment if detected by gastroscopy and pathological examination.
Patients with early-stage gastric cancer have a very high cure rate, with a 5-year survival rate of more than 80%, after aggressive surgical treatment with chemotherapy, but the specific cure is based on the specific pathological stage, combined with the pathological staging of the tumor and the patient’s own physical condition.